World
Why the three biggest vaccine makers failed on Covid
GlaxoSmithKline, Merck and Sanofi are left playing catch-up to upstarts with new technology
As pharmaceutical companies raced to develop Covid-19 vaccines, crossing the finishing line in record time, the world’s three biggest vaccine makers were also-rans.
GlaxoSmithKline, Merck and Sanofi are now left playing catch-up, after upstarts including Moderna and BioNTech demonstrated their mastery of new technologies that will shape the industry for years to come.
New Jersey-based Merck recently dropped its vaccine development programme completely, while Paris-based Sanofi and the UK’s GSK are having to redo an early-stage trial of the jab they are jointly developing, after a dosing mistake...
This article is reserved for Sunday Times Daily subscribers.
A subscription gives you full digital access to all Sunday Times Daily content.
Already subscribed? Simply sign in below.
Questions or problems?
Email helpdesk@timeslive.co.za or call 0860 52 52 00.